首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

2126658

成人人腦葉幹細胞整形外科市場：按來源、應用、最終用戶和地區分類

Adult Mesenchymal Stem Cells for Orthopedics Market, By Source, By Application, By End User, By Geography

出版日期: 2026年08月04日 | 出版商:

Coherent Market Insights | 英文 259 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，成人腦葉幹細胞在整形外科的市場規模將達到 1.95 億美元，到 2033 年將達到 3.823 億美元。預計 2026 年至 2033 年的複合年成長率將達到 10.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1.95億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	10.10%	2033年市場規模預測：	3.823億美元

成體間質幹細胞是具有分化潛能的多功能性間質細胞，可分化為成骨細胞、軟骨細胞和脂肪細胞，因此非常適合用於整形外科再生醫學。它們可從骨髓、脂肪組織、臍帶血和滑液中獲取，並用於治療多種肌肉骨骼損傷和疾病，包括骨關節炎、關節軟骨缺損、骨折、肌腱損傷和脊髓退化疾病。

由於整形外科和老齡化相關疾病發生率的上升，以及再生醫學的進步，全球整形外科成人間質幹細胞市場預計將快速成長。微創細胞療法在全球日益普及，這得益於越來越多的臨床證據證明間間質幹細胞療法的安全性和有效性，以及生技公司、製藥公司和研究機構投資的增加。

市場動態

全球成人腦葉幹細胞整形外科市場成長的主要促進因素包括：骨關節炎等肌肉骨骼和整形外科疾病的日益普遍、人口老化以及對再生醫學療法的旺盛需求。幹細胞分離、生產和移植技術的進步、臨床試驗數量的增加以及已開發市場監管支援也將促進市場成長。

然而，該市場面臨許多限制因素，包括高昂的治療和生產成本、複雜的監管流程以及缺乏長期臨床證據。儘管如此，現成的異體間質幹細胞產品的出現、組織工程和支架療法的創新，以及產學研合作帶來的投資增加，將為成人人類腦葉幹細胞整形外科市場帶來新的成長機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究基於以下參數分析了全球成人腦葉幹細胞整形外科市場的主要參與者：公司亮點、產品系列、關鍵亮點、財務表現和策略。
本報告提供的見解將使企業負責人和經營團隊能夠就未來的產品類型升級、市場擴張和行銷策略做出明智的決策。
這份《整形外科成人腦葉幹細胞全球市場》報告旨在為產業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用分析全球成人腦葉幹細胞整形外科市場時所採用的各種策略矩陣來輔助決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

公司簡介
- Mesoblast Limited
- Vericel Corporation
- MEDIPOST
- Anterogen Co., Ltd.
- TiGenix NV
- Thermo Fisher Scientific Inc.
- Lonza Group AG
- STEMCELL Technologies Canada Inc.
- PromoCell GmbH
- Stemedica Cell Technologies, Inc.

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9883

Adult Mesenchymal Stem Cells for Orthopedics Market is estimated to be valued at USD 195.0 Mn in 2026 and is expected to reach USD 382.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 195.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	10.10%	2033 Value Projection:	USD 382.3 Mn

Adult mesenchymal stem cells are multipotent mesenchymal cells with the potential to differentiate into osteoblasts, chondrocytes and adipocytes, therefore are most suitable for use in the orthopedic regenerative field. Sourced from bone marrow, adipose tissue, umbilical cord blood and synovial fluid, they are being employed for a number of musculoskeletal injuries and disorders, including osteoarthritis, articular cartilage defects, bone fracture, tendon injuries and spinal degenerative disease.

The global market for adult mesenchymal stem cells for orthopedics is predicted to be a rapidly growing field due to the increased incidence of orthopedic disorders and age-related conditions, as well as the advancement of regenerative medicine. The rise in clinical evidence for safe and efficacious mesenchymal stem cells therapy, along with an increase in investment from biotechnological firms, pharmaceutical companies and research establishments, is leading to the global application of minimally invasive cell treatments.

Market Dynamics

The global adult mesenchymal stem cells for orthopedics market are driven by increasing incidences of musculoskeletal disorders and orthopedics diseases like osteoarthritis, the growing aging population and high demand for regenerative therapeutic options. The market will also grow due to the development in stem cell isolation, manufacturing and delivery technology, increasing number of clinical trials and favorable regulatory support in developed markets.

However, a number of constraints are present in the market, such as high treatment and manufacturing costs, complex regulatory pathways, and limited long-term clinical evidence. Nevertheless, emergence of allogeneic off-the-shelf MSC products, innovations in tissue engineering and scaffold-based therapies, and increasing investments through industry-academia collaborations will offer new opportunities for growth in adult mesenchymal stem cells for orthopedics market.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global adult mesenchymal stem cells for orthopedics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Mesoblast Limited, Vericel Corporation, MEDIPOST, Anterogen Co., Ltd., TiGenix NV, Thermo Fisher Scientific Inc., Lonza Group AG, STEMCELL Technologies Canada Inc., PromoCell GmbH, and Stemedica Cell Technologies, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global adult mesenchymal stem cells for orthopedics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult mesenchymal stem cells for orthopedics market

Market Segmentation

Source Insights (Revenue, USD Mn, 2021 - 2033)
Bone Marrow
Adipose Tissue
Application Insights (Revenue, USD Mn, 2021 - 2033)
Knee Injuries
Shoulder Injuries
Ankle Injuries
Foot Injuries
Back and Spine Injuries
Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
Hospitals
Specialty Clinics
Academic and Research Institutions
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Mesoblast Limited
Vericel Corporation
MEDIPOST
Anterogen Co., Ltd.
TiGenix NV
Thermo Fisher Scientific Inc.
Lonza Group AG
STEMCELL Technologies Canada Inc.
PromoCell GmbH
Stemedica Cell Technologies, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Source
- Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Application
- Global Adult Mesenchymal Stem Cells for Orthopedics Market, By End User
- Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Industry Trends

4. Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Source, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Bone Marrow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Adipose Tissue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Knee Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Shoulder Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Ankle Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Foot Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Back and Spine Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Adult Mesenchymal Stem Cells for Orthopedics Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Adult Mesenchymal Stem Cells for Orthopedics Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Company Profile
- Mesoblast Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Vericel Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- MEDIPOST
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Anterogen Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- TiGenix NV
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Lonza Group AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- STEMCELL Technologies Canada Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- PromoCell GmbH
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Stemedica Cell Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies